Dr. Perrone's addition to XORTX's Clinical Advisory Board is viewed positively due to his extensive medical and professional experience, especially in ADPKD and kidney disease. His clinical research, trials, and regulatory agency work are anticipated to significantly contribute to XORTX's advanced clinical program and the XRX-OXY-201 registration trial.
$XORTX セラピューティクス(XRTX.US)$Out of shares. The last 2 times it reached support it ran up. Resistance is at 8.01 and 11.16. Support is at 2.25.
5
8
報告
AllSeeingGuy :
Did a bit of DD on this... R/S right before an ER?? Confusing. But, I like what I'm seeing. Buying a small bag. Here's to hoping that really is support.
Mcsnacks H Tupackスレ主AllSeeingGuy:
They are exercising damn warrants. That's what some of these companies are now doing after they RS. They lower the exercise price and then float them
Moomoo Buddy :
Dear client, thank you for your waiting, this stock has been delisted, whether it can be traded or not, you need to wait till 14th for further anouncement, perhaps some institutional investor can still trade it if you saw some trading volume for this counter, thank you for your support!
Moomoo BuddyPumpuiスレ主:
Dear client, thank you for your waiting, the scenario was just assuming, but base on the current anouncement and corp action, this stock is not available to trade by now, we seek for your understanding, thank you for your support!
$XORTX セラピューティクス(XRTX.US)$They now say that they will begin trading tomorrow on 11/14/23 at the 1/9 R/S! Lets see if it get the Pre R/S pop that a lot get? If so? you got to scalp fast! GL
XORTX セラピューティクスに関するコメント
📊⚡️📊
3 minutes ago, 7:00 AM EST
Via GlobeNewswire
MT Newswires· 3 mins ago
まだコメントはありません